Package 63868-822-05

Brand: olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 63868-822-05
Digits Only 6386882205
Product NDC 63868-822
Product ID 63868-822_8a32aa43-e0cf-f950-04b1-2a30384d2674
Description

1 BOTTLE, PLASTIC in 1 CARTON (63868-822-05) / 5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2021-01-01
Brand olopatadine hydrochloride ophthalmic solution
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "8a32aa43-e0cf-f950-04b1-2a30384d2674", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["5fa34b50-ffa3-4090-86f9-436f32f45cea"], "manufacturer_name": ["Chain Drug Marketing Association INC"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-822-05)  / 5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "63868-822-05", "marketing_start_date": "20210101"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "63868-822_8a32aa43-e0cf-f950-04b1-2a30384d2674", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "63868-822", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Chain Drug Marketing Association INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA209619", "marketing_category": "ANDA", "marketing_start_date": "20210101", "listing_expiration_date": "20261231"}